Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
Laura Calvillo(IRCCS Istituto Auxologico Italiano), Michael Brines(Northwell Health), Roberto Latini(Mario Negri Institute for Pharmacological Research), Monica Salio, Anthony Cerami(Araim Pharmaceuticals (United States)), Pietro Ghezzi(Brighton and Sussex Medical School), Annarosa Leri(Harvard University), Jan Kajstura(LifeArc), Piero Anversa(New York Medical College)
Cited by 613
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906